Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed its intellectual ...

Cancer research saved my daughter’s life, and despite setbacks, we must support these efforts to ensure more lives are saved ...

The six-month continuing resolution before Congress would cut $1.2 billion from the Pentagon's health research into deadly ...

DEVASTATED Nadia Sawalha fought back tears in an emotional video as she shared some heartbreaking news. Loose Women star ...

ER+/PR+ breast cancer, common and hormone-responsive, offers a better prognosis and is key in treatment research advancements ...

Life is funny sometimes. I passed by a car workshop the other day and saw my neighbour’s car — the same car that just missed ...

The FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer blockbuster’s patent expiry. Herceptin’s main US patent expires this month ...

evaluating evorpacept in combination with HERCEPTIN ® (trastuzumab), CYRAMZA ® (ramucirumab) and paclitaxel (Evo-TRP) against ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

AstraZeneca and Daiichi Sankyo's Enhertu has become the first HER2-directed drug to mount a patient survival benefit in a ...

An oncologist from Atrium Health outlines how saving time administering immunotherapy could have far-reaching benefits.

My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Oracle ...